Acer Therapeutics Inc
(NASDAQ:ACER)
$0.8302
0.0091[1.11%]
Last update: 8:09AM (Delayed 15-Minutes)
Get Real Time Here
$0.8302
0[0.00%]
Open0.810Close0.815
Vol / Avg.189.637K / 2.302MMkt Cap20.310M
Day Range0.810 - 0.84752 Wk Range0.552 - 4.520

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Acer Therapeutics Stock (NASDAQ:ACER), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10300

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Roth Capital
  • Roth MKM
  • EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acer Therapeutics

All Ratings (6)

Upgrades (0)

Downgrades (3)

Initiations (1)

Q

What is the target price for Acer Therapeutics (ACER)?

A

The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acer Therapeutics (ACER)?

A

The latest analyst rating for Acer Therapeutics (NASDAQ: ACER) was provided by HC Wainwright & Co., and Acer Therapeutics downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acer Therapeutics (ACER)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.

Q

Is the Analyst Rating Acer Therapeutics (ACER) correct?

A

While ratings are subjective and will change, the latest Acer Therapeutics (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics (ACER) is trading at is $0.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.